These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 34389366

  • 1. Influence of lipid matrix composition on biopharmaceutical properties of lipid nanoparticles.
    Keck CM, Specht D, Brüßler J.
    J Control Release; 2021 Oct 10; 338():149-163. PubMed ID: 34389366
    [Abstract] [Full Text] [Related]

  • 2. Natural Lipids as Structural Components of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Topical Delivery.
    Dobreva M, Stefanov S, Andonova V.
    Curr Pharm Des; 2020 Oct 10; 26(36):4524-4535. PubMed ID: 32410552
    [Abstract] [Full Text] [Related]

  • 3. Are lipid nanoparticles really superior? A holistic proof of concept study.
    Wiemann S, Keck CM.
    Drug Deliv Transl Res; 2022 Jun 10; 12(6):1433-1444. PubMed ID: 34476767
    [Abstract] [Full Text] [Related]

  • 4. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.
    Lombardi Borgia S, Regehly M, Sivaramakrishnan R, Mehnert W, Korting HC, Danker K, Röder B, Kramer KD, Schäfer-Korting M.
    J Control Release; 2005 Dec 10; 110(1):151-63. PubMed ID: 16297487
    [Abstract] [Full Text] [Related]

  • 5. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route.
    Lauterbach A, Müller-Goymann CC.
    Eur J Pharm Biopharm; 2015 Nov 10; 97(Pt A):152-63. PubMed ID: 26144664
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
    Mitri K, Shegokar R, Gohla S, Anselmi C, Müller RH.
    Int J Pharm; 2011 Jul 29; 414(1-2):267-75. PubMed ID: 21596122
    [Abstract] [Full Text] [Related]

  • 8. Current State of Lipid Nanoparticles (SLN and NLC) for Skin Applications.
    Eroğlu C, Sinani G, Ulker Z.
    Curr Pharm Des; 2023 Jul 29; 29(21):1632-1644. PubMed ID: 37534479
    [Abstract] [Full Text] [Related]

  • 9. Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion.
    Loo Ch, Basri M, Ismail R, Lau H, Tejo B, Kanthimathi M, Hassan H, Choo Y.
    Int J Nanomedicine; 2013 Jul 29; 8():13-22. PubMed ID: 23293516
    [Abstract] [Full Text] [Related]

  • 10. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.
    Gokce EH, Korkmaz E, Dellera E, Sandri G, Bonferoni MC, Ozer O.
    Int J Nanomedicine; 2012 Jul 29; 7():1841-50. PubMed ID: 22605933
    [Abstract] [Full Text] [Related]

  • 11. Lipid-Based Nanoparticles as Carriers for Dermal Delivery of Antioxidants.
    Lucia M.
    Curr Drug Metab; 2017 Jul 29; 18(5):469-480. PubMed ID: 28228079
    [Abstract] [Full Text] [Related]

  • 12. Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study.
    Arora R, Katiyar SS, Kushwah V, Jain S.
    Expert Opin Drug Deliv; 2017 Feb 29; 14(2):165-177. PubMed ID: 27882780
    [Abstract] [Full Text] [Related]

  • 13. Dermal Delivery of Lipid Nanoparticles: Effects on Skin and Assessment of Absorption and Safety.
    Pinto F, Fonseca LP, de Barros DPC.
    Adv Exp Med Biol; 2022 Feb 29; 1357():83-114. PubMed ID: 35583641
    [Abstract] [Full Text] [Related]

  • 14. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations.
    Jain S, Addan R, Kushwah V, Harde H, Mahajan RR.
    Int J Pharm; 2019 May 01; 562():96-104. PubMed ID: 30902706
    [Abstract] [Full Text] [Related]

  • 15. QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment.
    Amasya G, Aksu B, Badilli U, Onay-Besikci A, Tarimci N.
    Int J Pharm; 2019 May 30; 563():110-121. PubMed ID: 30935913
    [Abstract] [Full Text] [Related]

  • 16. Nanostructured lipid carriers (NLC) in cosmetic dermal products.
    Müller RH, Petersen RD, Hommoss A, Pardeike J.
    Adv Drug Deliv Rev; 2007 Jul 10; 59(6):522-30. PubMed ID: 17602783
    [Abstract] [Full Text] [Related]

  • 17. Formulation development of lipid nanoparticles: Improved lipid screening and development of tacrolimus loaded nanostructured lipid carriers (NLC).
    Kovačević AB, Müller RH, Keck CM.
    Int J Pharm; 2020 Feb 25; 576():118918. PubMed ID: 31870954
    [Abstract] [Full Text] [Related]

  • 18. Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery.
    Souto EB, Fangueiro JF, Fernandes AR, Cano A, Sanchez-Lopez E, Garcia ML, Severino P, Paganelli MO, Chaud MV, Silva AM.
    Heliyon; 2022 Feb 25; 8(2):e08938. PubMed ID: 35198788
    [Abstract] [Full Text] [Related]

  • 19. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy.
    Jores K, Haberland A, Wartewig S, Mäder K, Mehnert W.
    Pharm Res; 2005 Nov 25; 22(11):1887-97. PubMed ID: 16132349
    [Abstract] [Full Text] [Related]

  • 20. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
    Pardeike J, Hommoss A, Müller RH.
    Int J Pharm; 2009 Jan 21; 366(1-2):170-84. PubMed ID: 18992314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.